Effects of telemonitoring on glycaemic control and healthcare costs in type 2 diabetes: A randomised controlled trial
The DOI matches its Crossref record; 19 of the 20 references it cites were found in a registry or an index.
Abstract
Introduction: This study examined the effect of a telehealth intervention on the control of type 2 diabetes and subsequent potential cost-savings to the health system. Methods: This prospective randomised controlled trial randomised adults with type 2 diabetes to the intervention (diabetes program) or control (usual care) arm. Key eligibility criteria included an HbA1c level of at least 58 mmol/mol (7.5%) without severe or unstable comorbidities. All participants continued their usual healthcare, but participants in the intervention arm received additional diabetes care from a diabetes care coordinator via a home monitor that captured clinical measures. Data collected included biomedical, quality of life measures and healthcare (GP, outpatient and inpatient) costs. The primary outcome was HbA1c collected at baseline and 6 months. Analysis was conducted on a complete case intention-to-treat basis. The healthcare system perspective was taken to calculate the incremental cost per percentage-point reduction in HbA1c. Results: Results from 63 participants from each study arm were analysed. HbA1c in the intervention group decreased from a median 68 mmol/mol (8.4%) to 58 mmol/mol (7.5%), and remained unchanged in the control group at median 65 mmol/mol (8.1%) at the 6-month endpoint. The intervention effect on HbA1c change was statistically significant ( p = .004). Total healthcare costs in the intervention group, including the intervention costs, were lower (mean $3781 vs. $4662; p < .001) compared with usual care. Discussion: There was a clinically meaningful and statistically significant benefit from the telehealth intervention at a lower cost; thus, telehealth was cost-saving and produced greater health benefits compared with usual care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“With respect to glycemic control, telehealth appears noninferior (as good or superior) to traditional health care delivery for persons with T1D or T2D, particularly in those who require more interactions, are newly diagnosed, have higher A1C levels, are diagnosed with GDM, or have other comorbid conditions.1673–1681”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1677]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
KESSLER, R. C., ANDREWS, G., COLPE, L. J., HIRIPI, E., MROCZEK, D. K., NORMAND, S.-L. T., WALTERS, E. E., & ZASLAVSKY, A. M. (2002) · Psychological Medicine · doi:10.1017/s0033291702006074 · Cited by 10,327
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Darkins, A., Ryan, P., Kobb, R., Foster, L., Edmonson, E., Wakefield, B., & Lancaster, A. E. (2008) · Telemedicine and e-Health · doi:10.1089/tmj.2008.0021 · Cited by 597
Twenty years of telemedicine in chronic disease management – an evidence synthesis
Wootton, R. (2012) · Journal of Telemedicine and Telecare · doi:10.1258/jtt.2012.120219 · Cited by 545
Faruque, L. I., Wiebe, N., Ehteshami-Afshar, A., Liu, Y., Dianati-Maleki, N., Hemmelgarn, B. R., Manns, B. J., & Tonelli, M. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.150885 · Cited by 281
Home telehealth for diabetes management: a systematic review and meta‐analysis
Polisena, J., Tran, K., Cimon, K., Hutton, B., McGill, S., & Palmer, K. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01057.x · Cited by 239
Biologic and Quality-of-Life Outcomes From the Mediterranean Lifestyle Program
Toobert, D. J., Glasgow, R. E., Strycker, L. A., Barrera, M., Radcliffe, J. L., Wander, R. C., & Bagdade, J. D. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2288 · Cited by 238
Farmer, A., Gibson, O. J., Tarassenko, L., & Neil, A. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01627.x · Cited by 211
Home telemonitoring of patients with diabetes: a systematic assessment of observed effects
Jaana, M., & Paré, G. (2007) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2006.00686.x · Cited by 178
Research works printed but not linked: 2
- National Health and Hospitals Reform Commission, 2009, A Healthier Future for All Australians – Final Report
- Carlisle K, 2012, Stud Health Technol Inform, 182, 43
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Timmons, A. C., Duong, J. B., Simo Fiallo, N., Lee, T., Vo, H. P. Q., Ahle, M. W., Comer, J. S., Brewer, L. C., Frazier, S. L., & Chaspari, T. (2023) · Perspectives on Psychological Science · doi:10.1177/17456916221134490 · Cited by 263
“automated and assistive technologies (Davenport & Kalakota, 2019; Noah et al., 2018; Queirós et al., 2018; Warren et al., 2018).”
The Empirical Evidence for the Telemedicine Intervention in Diabetes Management
Bashshur, R. L., Shannon, G. W., Smith, B. R., & Woodward, M. A. (2015) · Telemedicine and e-Health · doi:10.1089/tmj.2015.0029 · Cited by 102
Wu, C., Wu, Z., Yang, L., Zhu, W., Zhang, M., Zhu, Q., Chen, X., & Pan, Y. (2018) · Medicine · doi:10.1097/md.0000000000012962 · Cited by 86
Rinaldi, G., Hijazi, A., & Haghparast-Bidgoli, H. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108084 · Cited by 85
Metadata
- Authors
- Warren, R., Carlisle, K., Mihala, G., & Scuffham, P. A.
- Affiliations
- James Cook University (AU)
- Griffith University (AU)
- Corresponding author
- Warren, Robin
- Venue
- Journal of Telemedicine and Telecare
- Publisher
- SAGE Publications
- Published
- 2017-08-16
- Volume
- 24
- Issue
- 9
- Pages
- 586-595
- ISSN
- 1357-633X (ISSN-L)
- 1758-1109
- OpenAlex
- W2748226477
- Cited by
- 54
- References
- 20
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 7 · 2023: 7 · 2022: 9 · 2021: 9 · 2020: 9 · 2019: 1 · 2018: 3
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Telemedicine and Telecare (publishedVersion)
- PubMed (publishedVersion)
- ResearchOnline - JCU (James Cook University) (submittedVersion)
- Griffith Research Online (submittedVersion)
- Funders
- Australian Government
- Queensland Government
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, remote patient monitoring, telemedicine, glycemic control, HbA1c, health care costs, cost reduction, home blood glucose monitoring, quality of life
- MeSH terms
- Adult, Aged, Cost-Benefit Analysis, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Queensland, Health Care Costs, Telemedicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of telemonitoring on glycaemic control and healthcare costs in type 2 diabetes: A randomised controlled trial. https://app.cochat.ai/papers/10.1177/1357633x17723943
- The paper
- Warren, R., Carlisle, K., Mihala, G., & Scuffham, P. A. (2018). Effects of telemonitoring on glycaemic control and healthcare costs in type 2 diabetes: A randomised controlled trial. Journal of Telemedicine and Telecare. https://doi.org/10.1177/1357633x17723943
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.